Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in autoimmunity - PubMed (original) (raw)
Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in autoimmunity
A Corthay et al. J Autoimmun. 2001 Jun.
Abstract
Approximately 25% of mature T cells possess two distinct cytoplasmic T cell receptor (TCR) alpha-chains, due to productive gene rearrangements of both alleles. Expression of two different alpha-chains at the cell surface is a potential risk factor for development of autoimmunity. However, it has been difficult to determine the frequency of peripheral T cells with two different alpha-chains at the surface. Our new approach is based on comparing by flow cytometry the percentage of cells that express a given Valpha-chain between wild-type mice and mice that are hemizygous for a disrupted Tcra locus (Tcra+/-) and consequently unable to express two rearranged Tcra genes. We consistently found that approximately 8% of total peripheral T cells express two surface alpha-chains. The importance of dual alpha-T cells in autoimmunity was examined in a mouse model for rheumatoid arthritis, namely collagen-induced arthritis (CIA). No significant difference was observed between Tcra+/- mice and wild-type littermates, considering arthritis incidence, day of disease onset, and maximum arthritic score. We therefore conclude that there is incomplete phenotypic allelic exclusion in TCRalpha, and that the presence of a significant number of potentially multireactive T cells does not increase the susceptibility to develop autoimmune arthritis.
Copyright 2001 Academic Press.
Similar articles
- Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgene.
Griffiths MM, Nabozny GH, Hanson J, Harper DS, McCall S, Moder KG, Cannon GW, Luthra HS, David CS. Griffiths MM, et al. J Immunol. 1994 Sep 15;153(6):2758-68. J Immunol. 1994. PMID: 8077680 - Posttranslational regulation of TCR Valpha allelic exclusion during T cell differentiation.
Alam SM, Gascoigne NR. Alam SM, et al. J Immunol. 1998 Apr 15;160(8):3883-90. J Immunol. 1998. PMID: 9558094 - Role of the T cell receptor alpha chain in the development and phenotype of naturally arising CD4+CD25+ T cells.
Bosco N, Hung HC, Pasqual N, Jouvin-Marche E, Marche PN, Gascoigne NR, Ceredig R. Bosco N, et al. Mol Immunol. 2006 Feb;43(3):246-54. doi: 10.1016/j.molimm.2005.02.002. Mol Immunol. 2006. PMID: 16199261 - T-cell receptor transgenic mice in the study of autoimmune diseases.
Lafaille JJ. Lafaille JJ. J Autoimmun. 2004 Mar;22(2):95-106. doi: 10.1016/j.jaut.2003.10.007. J Autoimmun. 2004. PMID: 14987736 Review. - Immunopathogenesis of collagen arthritis.
Brand DD, Kang AH, Rosloniec EF. Brand DD, et al. Springer Semin Immunopathol. 2003 Aug;25(1):3-18. doi: 10.1007/s00281-003-0127-1. Springer Semin Immunopathol. 2003. PMID: 12904888 Review.
Cited by
- Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoires.
Volkmar M, Fakhr E, Zens S, Bury A, Offringa R, Gordon J, Huduti E, Wölfel T, Wölfel C. Volkmar M, et al. Front Immunol. 2023 Nov 23;14:1286688. doi: 10.3389/fimmu.2023.1286688. eCollection 2023. Front Immunol. 2023. PMID: 38077312 Free PMC article. - scRNA-seq revealed the special TCR β & α V(D)J allelic inclusion rearrangement and the high proportion dual (or more) TCR-expressing cells.
Zhu L, Peng Q, Li J, Wu Y, Wang J, Zhou D, Ma L, Yao X. Zhu L, et al. Cell Death Dis. 2023 Jul 31;14(7):487. doi: 10.1038/s41419-023-06004-7. Cell Death Dis. 2023. PMID: 37524693 Free PMC article. - Molecular mimicry and autoimmunity in the time of COVID-19.
Rojas M, Herrán M, Ramírez-Santana C, Leung PSC, Anaya JM, Ridgway WM, Gershwin ME. Rojas M, et al. J Autoimmun. 2023 Sep;139:103070. doi: 10.1016/j.jaut.2023.103070. Epub 2023 Jun 12. J Autoimmun. 2023. PMID: 37390745 Free PMC article. Review. - High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity.
Fu J, Khosravi-Maharlooei M, Sykes M. Fu J, et al. Front Immunol. 2021 Nov 5;12:777756. doi: 10.3389/fimmu.2021.777756. eCollection 2021. Front Immunol. 2021. PMID: 34804070 Free PMC article. Review. - T Cell Receptor Engineered Lymphocytes for Cancer Therapy.
Rollins MR, Spartz EJ, Stromnes IM. Rollins MR, et al. Curr Protoc Immunol. 2020 Jun;129(1):e97. doi: 10.1002/cpim.97. Curr Protoc Immunol. 2020. PMID: 32432843 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases